HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thiol proteinase expression and pathogenicity of Entamoeba histolytica.

Abstract
Expression of the 56-kilodalton (kDa) neutral thiol proteinase has been shown to correlate with the potential of clinical isolates of Entamoeba histolytica to produce invasive disease. A 56-kDa band was identified by gelatin substrate gel electrophoresis in 10 of 10 isolates from patients with colitis or amebic liver abscesses, but in only 1 of 10 isolates from asymptomatic patients. Pathogenic isolates appear capable of releasing significantly larger quantities of the proteinase, as measured by cleavage of a synthetic peptide substrate, ZRR-AMC (benzyloxy-carbonyl-arginine-arginine-4-amino-7-methylcoumarin). We have also shown that the proteinase is released during the course of clinical invasive amebic disease, as demonstrated by the presence of circulating antibodies detectable by enzyme-linked immunosorbent assay. These studies support the importance of the 56-kDa thiol proteinase in the pathogenesis of invasive amebiasis.
AuthorsS L Reed, W E Keene, J H McKerrow
JournalJournal of clinical microbiology (J Clin Microbiol) Vol. 27 Issue 12 Pg. 2772-7 (Dec 1989) ISSN: 0095-1137 [Print] United States
PMID2556432 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Cysteine Endopeptidases
Topics
  • Amebiasis (parasitology)
  • Animals
  • Cysteine Endopeptidases (analysis, biosynthesis)
  • Dysentery, Amebic (parasitology)
  • Electrophoresis, Polyacrylamide Gel
  • Electrophoresis, Starch Gel
  • Entamoeba histolytica (enzymology, pathogenicity)
  • Entamoebiasis (parasitology)
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Liver Abscess, Amebic (parasitology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: